Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo regulated UK pharmacy runs a Mounjaro price match scheme. Tirzepatide is a prescription-only medicine: its price reflects clinical assessment, genuine licensed supply chain, and ongoing prescriber oversight — not a commodity you can haggle down like a TV deal. Private Mounjaro pricing in the UK has risen sharply since Eli Lilly's September 2025 list-price increase, with reported monthly costs now ranging roughly £149–£375 depending on the dose and the provider. The right question isn't which clinic will match a competitor's number, it's what that number actually includes. As a prescription-only medicine, Mounjaro can only be legally supplied following a clinical assessment by a qualified prescriber; any service skipping that step is operating outside UK law.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide's UK list price changed substantially on 1 September 2025, when Eli Lilly raised the wholesale price across the range, the highest-dose pen moving from around £122 to around £330 per four-week supply, as widely reported at the time. That shift cascaded into private pharmacy pricing almost immediately. Providers who had been competing on low headline numbers faced a stark choice: absorb an impossible margin or reprice. Many repriced. The idea that a credible UK pharmacy could still offer a price-match guarantee against rivals is, in most cases, a maths problem that doesn't resolve.
NICE's appraisal of tirzepatide (TA1026, published in December 2024) confirmed the medicine's clinical value, which has only intensified demand. High demand alongside constrained licensed supply means rock-bottom prices are a red flag, not a selling point. If you're wondering whether you can find discounted Mounjaro from a legitimate source, that's worth reading before you hand over card details.
The specific cost for each dose is shown clearly on our treatment page, so there's no guesswork. If you're trying to understand how the dose ladder affects what you pay, our Mounjaro cost overview covers the full picture.
A private Mounjaro price can be quoted as a medicine cost only, stripping out several things that are legally required for the prescription to exist in the first place. Consultation fees, prescription fees, clinical review on repeat orders, delivery charges, and access to prescriber support if a side effect appears mid-cycle: these can add £20–£50 or more per order depending on the provider, sometimes on top of an ongoing subscription you didn't clock at sign-up.
For a medicine that requires monthly re-ordering and clinical oversight for as long as you're using it, the cost of aftercare isn't optional. The NHS England guidance on weight-management injections is explicit that patients need ongoing clinical support, not just a prescription and a pen. Factoring in every element before comparing prices gives you a more honest picture than scanning for the lowest opening figure.
We understand the instinct to look for a deal. Mounjaro is a significant monthly outlay, and the price increase last year made that more acute. But the comparison that protects you is between full, inclusive packages, not stripped-back headline numbers. Our page on the Mounjaro 5 mg price, which breaks down what that tier costs when everything is included, is worth reading alongside this.
A price match on a pair of trainers gets you the same product for less money. A price match on a prescription-only injectable medicine is a different proposition entirely, because the 'product' isn't just the pen. It's the clinical assessment, the identity verification, the prescriber's judgment on your history, the supply chain from an authorised Lilly distributor, and the support if something feels wrong at week three.
The MHRA has been unambiguous: fake tirzepatide pens have been manufactured and sold in the UK, and in October 2025 enforcement teams raided an illicit site in Northampton that was producing counterfeit versions. The counterfeit risk is real, and the pattern is consistent, prices well below market, sales without a prescription, often via social media channels. You can report suspected sellers to the MHRA via Yellow Card, and you can verify any online pharmacy's legitimacy on the GPhC register, our registration number is 9012878.
At nume, we don't run price-match offers. We're not trying to win on price. A named prescriber reviews every consultation; every repeat is clinically re-checked; the medicine arrives from the licensed UK supply chain, tracked and in plain packaging. That's what the price covers. If you want to explore whether treatment is clinically right for you, our prescribers are the place to start, speak to our prescribers and begin your free consultation.
For broader context on how tirzepatide pricing has shifted, the Mounjaro price increase page explains what changed and why, and our tirzepatide overview covers the clinical background if you're still weighing up whether this treatment makes sense for you. If you're specifically on the starting dose, our Mounjaro 5mg price match page sets out what that guarantee involves and where it applies.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.